Author | Sara M. Tolaney, MD, MPH


Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets

June 30, 2017

This video examines an early trial studying abemaciclib for the treatment of brain metastases in patients with hormone receptor–positive, HER2-negative breast cancer.

Long-Term Data Confirm TH Benefit in Early HER2-Positive Breast Cancer

June 30, 2017

This video highlights 7-year follow-up data from the APT trial, which studied adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

Possible to Reduce Treatment Burden in HER2-Positive Breast Cancer?

March 01, 2017

This video examines the idea of using clinical features (age, tumor size) to reduce treatment burden in patients with HER2-positive breast cancer.

Adjuvant Chemotherapy Options in HER2-Positive Breast Cancer

March 01, 2017

This video examines chemotherapy options for HER2-positive breast cancer in the adjuvant setting, and what evidence there is for alternatives to an anthracycline backbone.